|Home Page : www.otcjournal.com
Email Questions or Comments To: email@example.com
OTC Journal Members:
When I published my first edition on Luxeyard (LUXR) April 12th, the company in the middle of the movement that will revolutionize the retail buying experience online, I stated my initial price target was $1.00, and my long term price target was $3.
In follow on editions, I set $1.50 and then $2 as new primary and secondary price target as the stock was trading extrordinarily well.
Yesterday, towards the close of market, LUXR traded up through $2 very nicely on huge volume, and I took the opportunity to follow my own suggestion and complete the sales of all of my free trading shares. I am still a holder of restricted shares as I invested directly in the company through a private placement. Those shares represent my long term position now.
From $.80 to $2 is 150% on your money in one month. I wish they were all like that.
I don't know if the stock will run a lot higher, or if the stock will present another great entry level. I'm very happy with this profit on the trading shares.
If you read about LUXR, VRNG, LUVU, or PLPL- fear not. Next week I'll be introducing a giant new idea, and I believe you will absolutely love it. This company has a product that has taken Australia, New Zealand, and the Middle East by storm, and is coming to the good old USA to replicate its success in a market 30 times the size of the aformentioned.
Stand by........ This one could rival a few of the best ideas I've had in 14 years.
A reminder: Catch me live on TV every Monday from 12 to 2PM eastern.
The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them or third parties as payment for publishing information and opinions about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions, if any, that the Newsletter or its principals presently maintain in the securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities. The Newsletter and its principals reserve the right to acquire additional shares or liquidate some or all of the positions they may hold in the issuer’s securities at any time in the future without further notice. These publications should not be considered to be independent publications concerning the company.
All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties.
The information found in this profile is protected by the copyright laws of the United States and may not be copied, or reproduced in any way without the express written consent of the editors of otcjournal.com.